Ivi rma global1/7/2024 ![]() IVI Middle East has an exceptional infrastructure backed by ESHRE trained doctors. The research-driven approach to treatment methodology drives the higher success rates. IVI Middle East offers personalized treatment and advanced treatment methodologies in IVF. Since its formation, IVI Middle East has delivered significantly better medical outcomes whilst ensuring the safety of patients coupled with the highest ethical standards. The company is positioned to continue to deliver accelerated growth in a market that is growing at 10%+ every year. IVI Middle East is the largest global player in the Gulf region offering world-class facilities and clinical protocols comparable to the highest global success rates. The company has two full-service clinics in Abu Dhabi and Muscat along with one outpatient clinic in the Dubai. The merger between IVI and RMANJ has been performed under the legal advice of Garrigues Abogados (Spain/USA)/McDermott Will&Emery (USA) and the financial advice of Arcano Partners (Spain)/Dresner Partners (USA).Back to Transactions IVI RMA Global and other shareholders have sold their stake in IVI Middle East to Gulf Capitalįounded in 2015 by IVI (now IVIRMA), Suresh Soni, Dr Human Fatemi, IVI Middle East emerged as the leading IVF provider in the Middle East market. Along with IVI, we can seek new markets and bring hope to all those patients who have problems with infertility.” Last year, patients from more than 30 States of the United States and 40 other countries came to us in search of hope. Richard Scott said that “as a single global entity, there are no geographical or any other kind of limits to our commitment to provide fertility solutions based on scientific evidence in order to offer the best chance of success in the shortest time possible. The ultimate aim of this union is to share the best practices and the latest technologies in every phase of the various treatments offered, always for the benefit of our patients.ĭr. The objective of both parties is to continue being leaders in the fields of research and scientific knowledge. This union will allow us to enhance our field of investigation, the fundamental pillar of IVI since its inception which has enabled us to achieve high rates of success, a fact that our patients value when choosing our services.” RMANJ is one of the leading business corporations in reproductive medicine of the United States. Being in the USA is a dream that now has come true and we have achieved our goal hand by hand with RMANJ which has proved to be the best companion. José Remohí declared that “after the merger with RMANJ we consolidate our position as the largest group of assisted reproduction in the world. The sharing of expertise such as an awarded international innovation, unprecedented patient care, and unsurpassable success rates are the essence of this merger. With ten clinics currently in the U.S.A., the initial objective of IVI-RMA Global is to continue its expansion in the United States. Scott) of such a young and revolutionary science endorses this union. The experience of several icons (professors José Remohí, Antonio Pellicer and Richard T. This merger will allow us to take full advantage of the expertise, experience and distinguishing elements of both companies for the benefit of our patients and employees”, explained Pellicer. We share much the same medical-scientific and business values and interests. The key to achieve this step was to go hand-in-hand with RMANJ. I have always pursued the goal of introducing my company in the USA and today I am pleased to announce that we have made it. Scott for many years and we admire and respect each other. Antonio Pellicer commented: “I have known Dr. IVI shareholders would retain a majority stake (approximately 70% belong to IVI and 30% to RMNAJ). After the merger of both companies, the group will reach around €300m revenues. Drews have made public in a press conference this merger that consolidates IVI-RMA Global as the largest group of assisted reproduction in the world.įollowing a year of negotiations IVI (Instituto Valenciano de Infertilidad) and RMNAJ (Reproductive Medicine Associates of New Jersey) have formalized the contract. Antonio Pellicer, accompanied by the Presidents of RMANJ, Paul A. IVI has announced on Thursday their entry in the USA by reaching an agreement with RMANJ to merge both companies. Award-winning innovation, unprecedented patient care, and superb results are the essence of this new group of global reproductive medicine.The initial goal of the new group, under the name IVI-RMA Global, is to continue its expansion in the U.S.After the merger of both companies, the group will reach around €300m revenues.IVI: one of the world’s largest egg banks.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |